Michigan Institute for Neurological Disorders

02/25/2026

Blood-based biomarkers are an important and evolving tool in the evaluation of certain neurological conditions, including multiple sclerosis and memory disorders.

At MIND, these lab tests are coordinated by our clinical team and used alongside neurological exams, imaging, and other diagnostic tools to help inform care when appropriate. In memory care, select blood biomarker testing is FDA-approved and represents a major advancement in earlier, less invasive evaluation.

As a practice committed to teaching, research, and next-generation care, MIND is actively involved in advancing how these tests are refined and used—bringing innovations into clinical practice thoughtfully and responsibly. Each patient’s testing plan is determined by their physician based on individual needs and clinical judgment.

To schedule a neurological evaluation, contact MIND at 248-553-0010.

02/23/2026

When should you see a neurologist? Dr. Joshua Nass, board-certified neurologist at MIND, shares warning signs you shouldn’t ignore.

Many neurological symptoms develop gradually — and waiting too long can delay diagnosis and treatment. According to Dr. Nass, you should consider seeing a neurologist if you’re experiencing:

• frequent or worsening headaches
• memory loss or changes in thinking
• unexplained numbness or weakness on one side
• tremor, balance issues, or coordination problems
• sudden changes in speech, vision, or personality

Early evaluation can provide answers, peace of mind, and access to more treatment options.

To schedule a neurological evaluation with a MIND neurologist, call 248-553-0010.

02/22/2026

Myth: Encephalitis always causes a high fever and obvious illness.

Fact: It can begin with subtle neurological changes — such as confusion, memory problems, seizures, or difficulty speaking — before other symptoms appear.

Because early signs can be easy to miss, awareness is key. Recognizing what’s unusual and seeking prompt medical care can make a meaningful difference.

Follow along as we break down common neurological myths each month.

Learn more at MINDonline.com.

02/20/2026

Today, on National Caregivers Day, we recognize the individuals who show up every day for those living with neurological conditions.

At MIND, we see you in our waiting rooms, infusion suites, and exam rooms — managing appointments, asking thoughtful questions, tracking medications, and advocating every step of the way.

You balance strength with compassion. You carry responsibility, worry, and hope — often all at once.

Caring for someone with a neurological condition is not easy. Your commitment makes a meaningful difference in their health, comfort, and quality of life.

From all of us at MIND, thank you for the care you provide — and for trusting us to be part of your loved one’s journey.

02/19/2026

CTE and Dementia: What the Latest Research Shows

New research provides important clarity about chronic traumatic encephalopathy (CTE).

A large autopsy study found that only advanced stages of CTE (Stage III and IV) were associated with increased odds of dementia. Early-stage CTE was not associated with cognitive symptoms or dementia.

Here’s what matters:

• Dementia risk appears to depend on CTE severity
• CTE can only be diagnosed after death
• Persistent cognitive symptoms should be evaluated

Memory changes or thinking concerns deserve thoughtful neurological assessment.

At MIND, our physicians provide comprehensive evaluation and individualized care for cognitive and memory concerns.

Read more: https://bit.ly/4kOtgrG

Dementia risk depended on CTE severity

02/18/2026

February is American Heart Month — and heart health is brain health.

High blood pressure, diabetes, and high cholesterol don’t just affect your heart. They increase the risk of stroke, vascular dementia, and cognitive decline.

Protecting your brain starts with protecting your cardiovascular health.

If you have concerns about memory, stroke risk, or neurological symptoms, our physicians are here to help.

Learn more at MINDonline.com

02/17/2026

New research is helping us better understand how closely the brain and heart work together — especially during and after a heart attack.

Researchers at UC San Diego found that signals from the brain may influence inflammation in the heart following a heart attack. This may help explain why stress and nervous system activity can affect recovery. In early studies, calming certain brain pathways reduced inflammation and supported healthier heart function.

While this research is still in its early stages, it reinforces an important message for patients: your brain and heart are deeply connected. Managing stress, supporting nervous system health, and taking care of your overall well-being can play a meaningful role in recovery and long-term health.

Read more from NPR: https://n.pr/46d6yDs

Researchers discovered a feedback loop between nerve cells, the immune system and the heart. They think it shows promise as a target for future therapies.

02/13/2026

We recently asked patients to share what “What MIND Means to Me” in their own words — and their responses remind us why we do what we do.

Thank you to our patients across all MIND locations for allowing us to be part of your care! 💘

02/12/2026

Stroke recovery can raise a lot of “Is this normal?” questions.

Some changes can happen during recovery, while others should be checked right away.

Changes in energy, progress, or mood can occur — but new or worsening symptoms should always be evaluated.

To schedule a neurological evaluation, contact MIND at 248-553-0010.

02/10/2026

Physician Spotlight: Dr. Joseph Kassa

Dr. Joseph Kassa is a board-certified neurologist at MIND who cares for patients with complex neurological conditions, including migraine, multiple sclerosis, stroke, Parkinson’s disease, spasticity, dystonia, and other complex neurological conditions.

Known for his thoughtful and thorough approach, Dr. Kassa focuses on understanding each patient’s symptoms, explaining options clearly, and building treatment plans together with patients and families.

02/09/2026

Epilepsy isn’t just about seizures. It affects how you work, drive, plan a family, and feel safe in everyday life.

At MIND, we look beyond diagnosis and medication. Our neurologists, EEG technologists, and care team work together to help patients manage the real-life challenges that come with epilepsy — with care that’s personal, practical, and built around each individual.

Our focus is on comprehensive, compassionate care tailored to the whole person, not just the condition. If you or a loved one is navigating life with epilepsy, our team is here to help.

Call us at (248) 553-0010 to learn more.

02/06/2026

A recent article discusses emerging research on a blood-based test designed to help physicians better understand disease activity in multiple sclerosis.

The study referenced in this coverage included Dr. Taylor (Gonyou) Hess, a fellowship-trained MS neurologist at the Michigan Institute for Neurological Disorders (MIND), who served as an investigator on research evaluating how biomarker data can support more informed treatment decisions over time.

This type of testing looks at multiple biological signals linked to MS activity — such as immune system behavior, nerve injury, inflammation, and myelin damage or repair — helping clinicians gain additional insight alongside imaging and exams.

At MIND, blood-based biomarker testing may be used in select cases when clinically appropriate.

Read the article from Rare Disease Advisor – It’s Now Easier to Get the New MS Test:
https://bit.ly/4rtwP8C